These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 16546673

  • 1. Brain SPECT imaging and whole-body biodistribution with [(123)I]ADAM - a serotonin transporter radiotracer in healthy human subjects.
    Lin KJ, Liu CY, Wey SP, Hsiao IT, Wu J, Fu YK, Yen TC.
    Nucl Med Biol; 2006 Feb; 33(2):193-202. PubMed ID: 16546673
    [Abstract] [Full Text] [Related]

  • 2. Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.
    Newberg AB, Plössl K, Mozley PD, Stubbs JB, Wintering N, Udeshi M, Alavi A, Kauppinen T, Kung HF.
    J Nucl Med; 2004 May; 45(5):834-41. PubMed ID: 15136634
    [Abstract] [Full Text] [Related]

  • 3. Brain kinetics of the new selective serotonin transporter tracer [(123)I]ADAM in healthy young adults.
    Booij J, de Win MM.
    Nucl Med Biol; 2006 Feb; 33(2):185-91. PubMed ID: 16546672
    [Abstract] [Full Text] [Related]

  • 4. In vivo quantification by SPECT of [123I] ADAM bound to serotonin transporters in the brains of rabbits.
    Ye XX, Hwang JJ, Hsieh JF, Chen JC, Chou YT, Tu KY, Wey SP, Ting G.
    Nucl Med Biol; 2004 Nov; 31(8):995-1003. PubMed ID: 15607481
    [Abstract] [Full Text] [Related]

  • 5. SPECT of serotonin transporters using 123I-ADAM: optimal imaging time after bolus injection and long-term test-retest in healthy volunteers.
    Catafau AM, Pérez V, Penengo MM, Bullich S, Danús M, Puigdemont D, Pascual JC, Corripio I, Llop J, Perich J, Alvarez E.
    J Nucl Med; 2005 Aug; 46(8):1301-9. PubMed ID: 16085586
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of the binding sites for 123I-ADAM and the relationship to the serotonin transporter in rat and mouse brains using quantitative autoradiography.
    Lin KJ, Yen TC, Wey SP, Hwang JJ, Ye XX, Tzen KY, Fu YK, Chen JC.
    J Nucl Med; 2004 Apr; 45(4):673-81. PubMed ID: 15073265
    [Abstract] [Full Text] [Related]

  • 8. Binding kinetics of 123I[ADAM] in healthy controls: a selective SERT radioligand.
    Sacher J, Asenbaum S, Klein N, Geiss-Granadia T, Mossaheb N, Poetzi C, Attarbaschi T, Lanzenberger R, Spindelegger C, Rabas A, Heinze G, Dudczak R, Kasper S, Tauscher J.
    Int J Neuropsychopharmacol; 2007 Apr; 10(2):211-8. PubMed ID: 16487452
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the Serotonin Transporter Ligand 123I-ADAM for SPECT Studies on Humans.
    Frokjaer VG, Pinborg LH, Madsen J, de Nijs R, Svarer C, Wagner A, Knudsen GM.
    J Nucl Med; 2008 Feb; 49(2):247-54. PubMed ID: 18199621
    [Abstract] [Full Text] [Related]

  • 10. 2-((2-((dimethylamino)methyl)phenyl)thio)-5-iodophenylamine (ADAM): an improved serotonin transporter ligand.
    Oya S, Choi SR, Hou C, Mu M, Kung MP, Acton PD, Siciliano M, Kung HF.
    Nucl Med Biol; 2000 Apr; 27(3):249-54. PubMed ID: 10832081
    [Abstract] [Full Text] [Related]

  • 11. Characterization of FlipIDAM as a SERT-selective SPECT imaging agent.
    Lemoine L, Lieberman BP, Ploessl K, Zheng P, Kung HF.
    Nucl Med Biol; 2013 Oct; 40(7):879-86. PubMed ID: 23856117
    [Abstract] [Full Text] [Related]

  • 12. Quantification of serotonin transporters in nonhuman primates using [(123)I]ADAM and SPECT.
    Acton PD, Choi SR, Hou C, Plössl K, Kung HF.
    J Nucl Med; 2001 Oct; 42(10):1556-62. PubMed ID: 11585873
    [Abstract] [Full Text] [Related]

  • 13. Imaging serotonin transporters with 123I-ADAM brain SPECT in healthy non-human primates.
    Huang WS, Ma KH, Cheng CY, Chen CY, Fu YK, Chou YH, Wey SP, Liu JC.
    Nucl Med Commun; 2004 May; 25(5):515-9. PubMed ID: 15100512
    [Abstract] [Full Text] [Related]

  • 14. Measuring SSRI occupancy of SERT using the novel tracer [123I]ADAM: a SPECT validation study.
    Erlandsson K, Sivananthan T, Lui D, Spezzi A, Townsend CE, Mu S, Lucas R, Warrington S, Ell PJ.
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1329-36. PubMed ID: 16133377
    [Abstract] [Full Text] [Related]

  • 15. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG, Choi SR, Fang P, Hou C, Acton PD, Cardi C, Saffer JR, Greenberg JH, Karp JS, Kung HF, Shiue CY.
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Imaging serotonin transporters using [123I]ADAM SPECT in a parkinsonian primate model.
    Ma KH, Huang WS, Huang SY, Cheng CY, Chen CY, Shen LH, Liu JC, Fu YK.
    Appl Radiat Isot; 2008 Dec; 66(12):1799-803. PubMed ID: 18703341
    [Abstract] [Full Text] [Related]

  • 18. 123I-ADAM binding to serotonin transporters in patients with major depression and healthy controls: a preliminary study.
    Newberg AB, Amsterdam JD, Wintering N, Ploessl K, Swanson RL, Shults J, Alavi A.
    J Nucl Med; 2005 Jun; 46(6):973-7. PubMed ID: 15937308
    [Abstract] [Full Text] [Related]

  • 19. Selective in vitro and in vivo binding of [(125)I]ADAM to serotonin transporters in rat brain.
    Choi SR, Hou C, Oya S, Mu M, Kung MP, Siciliano M, Acton PD, Kung HF.
    Synapse; 2000 Dec 15; 38(4):403-12. PubMed ID: 11044887
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.